Heart pump study for very severe heart failure
Part of Heart & circulation clinical trials.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Be able to sign consent to join the study
- Have a body size large enough (body surface area at least 1.2 m²)
- Have very weak heart pumping (left ejection fraction 25% or less) and be class IV (severe symptoms even at rest)
- Despite best heart-failure medicines, you must fit at least one “not improving” situation (for example, very poor exercise test results, worsening organ function, or needing heart support/inotrope medicines)
- Not have major exclusion issues like dangerous blood clotting problems, serious infection, very severe lung disease, recent stroke, kidney failure needing dialysis, or high surgical risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This study tests a new type of heart pump (the DuoCor 2) designed to support both the left and right sides of the heart. The pump is implanted during surgery and may help people with very advanced heart failure feel better and live longer.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
Hear when a new Refractory Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.